- Home
- ALTS vs ADAG Comparison
ALTS vs ADAG Comparison
Compare ALTS & ADAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTS
- ADAG
- Stock Information
- Founded
- ALTS 1976
- ADAG 2011
- Country
- ALTS United States
- ADAG China
- Employees
- ALTS N/A
- ADAG N/A
- Industry
- ALTS
- ADAG Biotechnology: Pharmaceutical Preparations
- Sector
- ALTS
- ADAG Health Care
- Exchange
- ALTS NYSE
- ADAG Nasdaq
- Market Cap
- ALTS 159.4M
- ADAG 91.4M
- IPO Year
- ALTS N/A
- ADAG 2021
- Fundamental
- Price
- ALTS $7.88
- ADAG $1.92
- Analyst Decision
- ALTS
- ADAG Strong Buy
- Analyst Count
- ALTS 0
- ADAG 1
- Target Price
- ALTS N/A
- ADAG $8.00
- AVG Volume (30 Days)
- ALTS 298.1K
- ADAG 51.2K
- Earning Date
- ALTS 08-18-2025
- ADAG 07-24-2025
- Dividend Yield
- ALTS N/A
- ADAG N/A
- EPS Growth
- ALTS N/A
- ADAG N/A
- EPS
- ALTS N/A
- ADAG N/A
- Revenue
- ALTS $18,046,000.00
- ADAG $103,204.00
- Revenue This Year
- ALTS $185.91
- ADAG $6,488.89
- Revenue Next Year
- ALTS $64.93
- ADAG $57.50
- P/E Ratio
- ALTS N/A
- ADAG N/A
- Revenue Growth
- ALTS N/A
- ADAG N/A
- 52 Week Low
- ALTS $1.29
- ADAG $1.33
- 52 Week High
- ALTS $10.95
- ADAG $3.58
- Technical
- Relative Strength Index (RSI)
- ALTS 47.13
- ADAG 56.78
- Support Level
- ALTS $7.06
- ADAG $1.74
- Resistance Level
- ALTS $8.38
- ADAG $1.98
- Average True Range (ATR)
- ALTS 0.91
- ADAG 0.12
- MACD
- ALTS -0.17
- ADAG -0.00
- Stochastic Oscillator
- ALTS 33.51
- ADAG 72.22
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.